Immune checkpoint inhibitor–related dermatologic adverse events-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitor–related dermatologic adverse events

Published:2020-11 Issue:5 Volume:83 Page:1255-1268
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Geisler Amaris N.,Phillips Gregory S.,Barrios Dulce M.,Wu Jennifer,Leung Donald Y.M.,Moy Andrea P.,Kern Jeffrey A.,Lacouture Mario E.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Dermatology

Reference116 articles.

1. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group;Puzanov;J Immunother Cancer,2017

2. Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity;Inno;Tumori,2017

3. Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma;Shoushtari;JAMA Oncol,2018

4. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis;Wang;JAMA Oncol,2018

5. Ipilimumab in patients with cancer and the management of dermatologic adverse events;Lacouture;J Am Acad Dermatol,2014

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity;Hematology/Oncology Clinics of North America;2024-10

2. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04

3. A Case of Bullous Pemphigoid with Significant Infiltration of CD4-Positive T Cells during Treatment with Pembrolizumab, Accompanied by Pembrolizumab-Induced Multi-Organ Dysfunction;Diagnostics;2024-09-04

4. Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment—Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor Therapies with Machine Learning Perspectives;Life;2024-08-25

5. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors;World Journal of Clinical Oncology;2024-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3